Related Experiment Video
Updated: Aug 15, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Analysing DNA patents in relation with diagnostic genetic testing
Birgit Verbeure1, Gert Matthijs, Geertrui Van Overwalle
1Centre for Intellectual Property Rights, Faculty of Law, Catholic University of Leuven, Leuven, Belgium.
This study introduces tools to analyze DNA patents for genetic diagnostic testing. It provides empirical data on patent claims, aiding researchers and clinicians in navigating genetic testing patent landscapes.
Area of Science:
- Biotechnology Law
- Intellectual Property
- Genetic Diagnostics
Background:
- The legal landscape of DNA patenting, particularly for diagnostic genetic testing, lacks comprehensive empirical data.
- Understanding patent claims is crucial for medical geneticists and researchers utilizing patented technologies.
Purpose of the Study:
- To develop and validate tools for systematically analyzing DNA patents relevant to diagnostic genetic testing.
- To create an empirical dataset of DNA patents and their claim classifications.
- To identify potential challenges faced by researchers and clinicians due to patented genetic testing technologies.
Main Methods:
- Development of a specialized search strategy to identify relevant DNA patents.
- Creation of a claim classification template for assessing patent subject matter.
- Application of these tools in a pilot study focusing on 11 hereditary disorders.
- Detailed analysis of patents related to familial breast and ovarian cancer genes.
Main Results:
- Successful development of a search strategy and classification template for DNA patents.
- Generation of a pilot dataset for DNA patents in selected hereditary disorders.
- Identification of specific issues encountered by medical geneticists and researchers with patented genetic testing technologies.
- Detailed patent analysis for familial breast and ovarian cancer genes.
Conclusions:
- The developed tools facilitate the creation of empirical data on DNA patents for genetic diagnostics.
- The findings highlight practical challenges in the patent landscape for medical geneticists and researchers.
- This work provides a foundation for a more transparent and navigable patent environment in genetic testing.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
Related Concept Videos
DNA Microarrays
Karyotyping
Pharmacogenomics: Identification of New Drug Targets
Modern Molecular Taxonomy